WHO ICTRP trial
A double-blind, randomised, placebo and mesalazine controlled phase II study to…
EUCTR2008-004610-27-BE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2008-004610-27-BE |
|---|---|
| Public title | A double-blind, randomised, placebo and mesalazine controlled phase II study to explore the safety and activity of dersalazine in patients with mild to moderate active colitis |
| Scientific title | A double-blind, randomised, placebo and mesalazine controlled phase II study to explore the safety and activity of dersalazine in patients with mild to moderate active colitis |
| Primary sponsor | Palau Pharma S.A. |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Hungary;Belgium;Spain |
| Conditions | Mild to moderate active ulcerative colitis MedDRA version: 9.1 Level: LLT Classification code 10045365 Term: Ulcerative colitis |
| Interventions | Product Name: Dersalazine sodium Product Code: UR-12746-S Pharmaceutical Form: Capsule* INN or Proposed INN: dersalazine sodium CAS Number: 367249-56-7 Current Sponsor code: UR-12746-S Concentration unit: mg milligram(s) Concentration type… |
| Registration date | Jul 24, 2008 |
| Target size | 90 |
| Secondary IDs | CR-IBD-1-08 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: